{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:44:22Z","timestamp":1785771862331,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.jamda.2014.11.002","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T18:02:42Z","timestamp":1418666562000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)"],"prefix":"10.1016","volume":"16","author":[{"given":"Clive","family":"Ballard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-0316","authenticated-orcid":false,"given":"Anne","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narenda","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Creese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soe Nyunt","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2014.11.002_bib1","unstructured":"Alzheimer's Disease International. World Alzheimer Report. 2009. Available at:\u00a0http:\/\/www.alz.co.uk\/research\/files\/WorldAlzheimerReport.pdf. Accessed December 2, 2012."},{"key":"10.1016\/j.jamda.2014.11.002_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gps.1858","article-title":"Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study","volume":"23","author":"Steinberg","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib3","unstructured":"National Institute for Health and Clinical Excellence (NICE). Dementia: Supporting people with dementia and their carers in health and social care. Available at:\u00a0https:\/\/www.nice.org.uk\/guidance\/cg42. 2006. Accessed June 16,\u00a02014."},{"key":"10.1016\/j.jamda.2014.11.002_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.JGP.0000221334.65330.55","article-title":"Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease","volume":"14","author":"Lyketsos","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib5","unstructured":"Alzheimer's Society Optimising treatment and care for behavioural and psychological symptoms of dementia: A best practice guide. Available at:\u00a0http:\/\/www.alzheimers.org.uk\/bpsdguide. 2012. Accessed April 23,\u00a02014."},{"key":"10.1016\/j.jamda.2014.11.002_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nrn1926","article-title":"Neuroleptic drugs in dementia: Benefits and harm","volume":"7","author":"Ballard","year":"2006","journal-title":"Nature Rev Neurosci"},{"key":"10.1016\/j.jamda.2014.11.002_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nrneurol.2009.39","article-title":"Management of agitation and aggression associated with Alzheimer disease","volume":"5","author":"Ballard","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jamda.2014.11.002_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1517\/14740338.2010.506711","article-title":"Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality","volume":"10","author":"Ballard","year":"2011","journal-title":"Expert opinion on drug safety"},{"key":"10.1016\/j.jamda.2014.11.002_bib10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1192\/bjp.bp.111.107631","article-title":"Antipsychotics in dementia: Prevalence and quality of antipsychotic drug prescribing in UK mental health services","volume":"201","author":"Barnes","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2014.11.002_bib12","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Nature reviews Neuroscience","volume":"355","author":"Schneider","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2014.11.002_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/089198879701000306","article-title":"Withdrawal of neuroleptic medications from institutionalized dementia patients: Results of a double-blind, baseline-treatment-controlled pilot study","volume":"10","author":"Bridges-Parlet","year":"1997","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jamda.2014.11.002_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4088\/JCP.v65n0120","article-title":"A\u00a03-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: The neuropsychiatric inventory median cutoff is a predictor of clinical outcome","volume":"65","author":"Ballard","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib15","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0050076","article-title":"A\u00a0randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)","volume":"5","author":"Ballard","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.jamda.2014.11.002_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1474-4422(08)70295-3","article-title":"The dementia antipsychotic withdrawal trial (DART\u2013AD): Long-term follow-up of a randomised placebo-controlled trial","volume":"8","author":"Ballard","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2014.11.002_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/gps.2630","article-title":"A\u00a06-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease","volume":"26","author":"Devanand","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1114058","article-title":"Relapse risk after discontinuation of risperidone in Alzheimer's disease","volume":"367","author":"Devanand","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2014.11.002_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/bmj.38782.575868.7C","article-title":"Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial","volume":"332","author":"Fossey","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2014.11.002_bib20","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.159.15.1733","article-title":"Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: A controlled, double-blind study","volume":"159","author":"Cohen-Mansfield","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jamda.2014.11.002_bib21","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1017\/S1041610209990998","volume":"21","author":"Ballard","year":"2009","journal-title":"Int Psychogeriatr\/IPA"},{"key":"10.1016\/j.jamda.2014.11.002_bib22","doi-asserted-by":"crossref","first-page":"e35185","DOI":"10.1371\/journal.pone.0035185","article-title":"Efficacy of memantine for agitation in Alzheimer's dementia: A randomised double\u2013blind placebo controlled trial","volume":"7","author":"Fox","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2014.11.002_bib23","first-page":"CD003154","article-title":"Memantine for dementia","author":"McShane","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jamda.2014.11.002_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.v69n0302","article-title":"Memantine for agitation\/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies","volume":"69","author":"Wilcock","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2014.11.002_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS\u2013ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2014.11.002_bib27","doi-asserted-by":"crossref","first-page":"M77","DOI":"10.1093\/geronj\/44.3.M77","article-title":"A\u00a0description of agitation in a nursing home","volume":"44","author":"Cohen-Mansfield","year":"1989","journal-title":"J\u00a0Gerontol"},{"key":"10.1016\/j.jamda.2014.11.002_bib28","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/1099-1166(200007)15:7<656::AID-GPS163>3.0.CO;2-Q","article-title":"The sensitivity to change over time of the Bristol Activities of Daily Living Scale in Alzheimer's disease","volume":"15","author":"Byrne","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2014.11.002_bib29","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2014.11.002_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini\u2013mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jamda.2014.11.002_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0404.1997.tb00299.x","article-title":"The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies","volume":"96","author":"Ballard","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jamda.2014.11.002_bib32","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study\u2013Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2014.11.002_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1041610297004869","article-title":"The GDS\/FAST staging system","volume":"9","author":"Auer","year":"1997","journal-title":"Int Psychogeriatr\/IPA"},{"key":"10.1016\/j.jamda.2014.11.002_bib34","unstructured":"Health & Social Care Information Centre. National Dementia and Antipsychotic Prescribing Audit. Available at:\u00a0http:\/\/www.hscic.gov.uk\/dementiaaudit. 2012. Accessed September 8,\u00a02014."}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101400749X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101400749X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T20:23:24Z","timestamp":1537993404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586101400749X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S152586101400749X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2014.11.002","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2014.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AMDA \u2013 The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}